About A1 There are over 5 billion users using basic applications today such email, notes, tasks that are not AI-native. Our mission is to build a proactive smart assistant for everyday users to bring intelligence to
About A1 There are over 5 billion users using basic applications today such email, notes, tasks that are not AI-native. Our mission is to build a proactive smart assistant for everyday users to bring intelligence to
About A1 There are over 5 billion users using basic applications today such email, notes, tasks that are not AI-native. Our mission is to build a proactive smart assistant for everyday users to bring intelligence to
About A1 There are over 5 billion users using basic applications today such email, notes, tasks that are not AI-native. Our mission is to build a proactive smart assistant for everyday users to bring intelligence to
About A1 There are over 5 billion users using basic applications today such email, notes, tasks that are not AI-native. Our mission is to build a proactive smart assistant for everyday users to bring intelligence to
About A1 There are over 5 billion users using basic applications today such email, notes, tasks that are not AI-native. Our mission is to build a proactive smart assistant for everyday users to bring intelligence to
About A1 There are over 5 billion users using basic applications today such email, notes, tasks that are not AI-native. Our mission is to build a proactive smart assistant for everyday users to bring intelligence to
Revolution Medicines is a late-stage clinical oncology company developing novel targeted therapies for patients with RAS-addicted cancers. The company’s R&D pipeline comprises RAS(ON) inhibitors designed to suppress diverse oncogenic variants of RAS proteins. The company’s RAS(ON)
Revolution Medicines is a late-stage clinical oncology company developing novel targeted therapies for patients with RAS-addicted cancers. The company’s R&D pipeline comprises RAS(ON) inhibitors designed to suppress diverse oncogenic variants of RAS proteins. The company’s RAS(ON)
Revolution Medicines is a late-stage clinical oncology company developing novel targeted therapies for patients with RAS-addicted cancers. The company’s R&D pipeline comprises RAS(ON) inhibitors designed to suppress diverse oncogenic variants of RAS proteins. The company’s RAS(ON)
Please note that this internship program is only open to students studying at universities based in Switzerland. About IISD The International Institute for Sustainable Development (IISD) is an award-winning independent think tank working to accelerate solutions
Your future starts here You shape and enhance our central document management platform, Alfresco, and develop solutions that simplify everyday work for our customers. As part of an agile team, you work with modern methodologies and
THE OPPORTUNITY Are you an AI-native software engineer ready to shape how enterprise brands appear in AI? The Adobe Brand Visibility team builds the systems that determine how enterprise brands appear in ChatGPT, Gemini, and the next generation
THE OPPORTUNITY Are you an AI-native software engineer ready to help enterprises stay visible in the era of AI? The Adobe Brand Visibility team builds the systems that determine how enterprise brands appear in ChatGPT, Gemini, and
THE OPPORTUNITY The way brands are discovered online is changing as search engines, AI assistants, and large language models increasingly shape how users find information and interact with content. Adobe’s Domain Experts team operates where SEO,
Company Description At Swissquote, we’re all in. All in to shake things up. All in to build the bank people actually want to use. All in to make finance less boring — and a lot more
Revolution Medicines is a late-stage clinical oncology company developing novel targeted therapies for patients with RAS-addicted cancers. The company’s R&D pipeline comprises RAS(ON) inhibitors designed to suppress diverse oncogenic variants of RAS proteins. The company’s RAS(ON)
THE OPPORTUNITY Are you an AI-native engineer who wants to own the full build–measure–learn loop for a product at the frontier of AI discovery? The Adobe Brand Visibility team builds the systems that determine how enterprise
Revolution Medicines is a late-stage clinical oncology company developing novel targeted therapies for patients with RAS-addicted cancers. The company’s R&D pipeline comprises RAS(ON) inhibitors designed to suppress diverse oncogenic variants of RAS proteins. The company’s RAS(ON)
Revolution Medicines is a late-stage clinical oncology company developing novel targeted therapies for patients with RAS-addicted cancers. The company’s R&D pipeline comprises RAS(ON) inhibitors designed to suppress diverse oncogenic variants of RAS proteins. The company’s RAS(ON)